The Role of Genomics in the Development and Treatment of Multiple Myeloma: Understanding the Challenges and Opportunities
Genomic advances in myeloma now guide treatment selection and detect minimal residual disease through blood tests.
A comprehensive review of multiple myeloma genomics covers recent advances in driver mutations, copy number variations, epigenetic changes, and non-coding RNAs using high-throughput sequencing technologies. It outlines clinical applications including risk stratification, treatment selection, and liquid biopsy-based MRD monitoring.
What the study was
- Study design
- Review
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- OncoTargets and Therapy
Why it surfaced
Routine comprehensive review; adequate coverage of MM genomics landscape but no novel primary data.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.